Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Transdifferentiation | 3 | 2017 | 186 | 0.640 |
Why?
|
| Adenocarcinoma | 14 | 2019 | 6364 | 0.550 |
Why?
|
| Lung Neoplasms | 18 | 2019 | 13451 | 0.500 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2016 | 4044 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2019 | 5337 | 0.260 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2017 | 5389 | 0.250 |
Why?
|
| Protein-Lysine 6-Oxidase | 2 | 2014 | 55 | 0.200 |
Why?
|
| Phosphoproteins | 3 | 2015 | 2446 | 0.190 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2015 | 595 | 0.170 |
Why?
|
| Turtles | 1 | 2019 | 40 | 0.160 |
Why?
|
| Keratin-14 | 1 | 2019 | 57 | 0.160 |
Why?
|
| Peptide Hormones | 1 | 2019 | 133 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2014 | 833 | 0.150 |
Why?
|
| Mice, Nude | 4 | 2019 | 3618 | 0.140 |
Why?
|
| Axonemal Dyneins | 1 | 2016 | 25 | 0.140 |
Why?
|
| Extracellular Matrix | 3 | 2017 | 1727 | 0.130 |
Why?
|
| Lung | 3 | 2015 | 10033 | 0.130 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2019 | 266 | 0.130 |
Why?
|
| Oncogenes | 2 | 2011 | 1235 | 0.120 |
Why?
|
| Spermatozoa | 1 | 2019 | 629 | 0.120 |
Why?
|
| Reproduction | 1 | 2019 | 641 | 0.120 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2015 | 202 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 2900 | 0.110 |
Why?
|
| ras Proteins | 3 | 2012 | 1053 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2016 | 1608 | 0.090 |
Why?
|
| Genes, erbB-1 | 1 | 2011 | 161 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2012 | 228 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 6220 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2019 | 1761 | 0.080 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 1229 | 0.080 |
Why?
|
| Mutation | 5 | 2014 | 30198 | 0.070 |
Why?
|
| Repressor Proteins | 2 | 2015 | 2968 | 0.070 |
Why?
|
| Trans-Activators | 2 | 2014 | 2850 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 5696 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 17075 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2012 | 4520 | 0.060 |
Why?
|
| Receptor, erbB-2 | 2 | 2012 | 2593 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4392 | 0.050 |
Why?
|
| Mice | 9 | 2019 | 81819 | 0.050 |
Why?
|
| Gene Fusion | 2 | 2016 | 357 | 0.050 |
Why?
|
| Animals | 11 | 2019 | 168764 | 0.050 |
Why?
|
| Smoking | 3 | 2012 | 9081 | 0.040 |
Why?
|
| Oviducts | 1 | 2019 | 11 | 0.040 |
Why?
|
| Anoikis | 1 | 2019 | 49 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 5783 | 0.040 |
Why?
|
| Cell Cycle Proteins | 3 | 2015 | 3430 | 0.040 |
Why?
|
| DNA Mutational Analysis | 3 | 2012 | 4108 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2019 | 4137 | 0.040 |
Why?
|
| Genomics | 1 | 2014 | 5929 | 0.040 |
Why?
|
| Transplantation, Heterologous | 2 | 2016 | 2394 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2019 | 4260 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2014 | 12131 | 0.040 |
Why?
|
| Epididymis | 1 | 2019 | 226 | 0.040 |
Why?
|
| Gene Dosage | 2 | 2012 | 1216 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2014 | 2927 | 0.030 |
Why?
|
| Humans | 19 | 2019 | 765968 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2016 | 147 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 474 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 2942 | 0.030 |
Why?
|
| Base Sequence | 2 | 2019 | 12403 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 4893 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 479 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2015 | 125 | 0.030 |
Why?
|
| China | 2 | 2011 | 2385 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 9550 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 8611 | 0.030 |
Why?
|
| Sirtuins | 1 | 2016 | 322 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2019 | 1088 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2011 | 18071 | 0.030 |
Why?
|
| Male | 10 | 2019 | 363698 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1410 | 0.030 |
Why?
|
| Androgens | 1 | 2019 | 1279 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 2014 | 0.020 |
Why?
|
| Autophagy | 1 | 2019 | 1351 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2016 | 864 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2015 | 1061 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 18293 | 0.020 |
Why?
|
| Female | 9 | 2019 | 396112 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2017 | 1611 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 370 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2015 | 3586 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10429 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 2218 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2010 | 663 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 1745 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 2844 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2140 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2012 | 1091 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 618 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2880 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 1325 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2010 | 904 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2011 | 12768 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 2391 | 0.020 |
Why?
|
| Middle Aged | 7 | 2014 | 223009 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2832 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 2428 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 3421 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 2796 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3432 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2019 | 18973 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3797 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4562 | 0.010 |
Why?
|
| Cell Line | 1 | 2016 | 15543 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3602 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9296 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 2056 | 0.010 |
Why?
|
| Prognosis | 2 | 2014 | 29922 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 2878 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14448 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7599 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4247 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 3596 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 17594 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11206 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16721 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13632 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11641 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 22332 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 7202 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12795 | 0.010 |
Why?
|
| Aged | 3 | 2012 | 171117 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23601 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39193 | 0.010 |
Why?
|
| Adult | 3 | 2011 | 223044 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 41649 | 0.000 |
Why?
|
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_